MedTrace Logo

The Efficacy and Safety of SGF200 on Immune Enhancement

NCT04930640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-06-18

No results posted yet for this study

Summary

This study was conducted to investigate the efficacy and safety of SGF200 on immune enhancement.

Conditions

  • Immunity

Interventions

DIETARY_SUPPLEMENT

SGF200 group

1 times a day, 1 capsule for 1 time, before breakfast meal, for 8 week

DIETARY_SUPPLEMENT

Placebo

Placebo for 8 week

Sponsors & Collaborators

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2021-04-06
Completion
2021-05-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04930640 on ClinicalTrials.gov